» Articles » PMID: 33475880

Prevalence of Osteoporosis Among the Elderly Population of Iran

Overview
Journal Arch Osteoporos
Publisher Springer
Date 2021 Jan 21
PMID 33475880
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Population aging has made osteoporosis and osteoporotic fractures an important health problem, especially in developing countries. This study aimed to explore the prevalence of osteoporosis and associated factors among the elderly population of the south-west of Iran.

Methods: Baseline data of the second stage of the Bushehr Elderly Health program was used. Spinal, total hip, or femoral neck osteoporosis was described as a BMD that lies 2.5 standard deviations or more, below the average values of a young healthy adult in the lumbar spine, total hip, or femoral neck, respectively. Osteoporosis at either site was defined as total osteoporosis. Age-standardized prevalence of osteoporosis was estimated. We used the modified Poisson regression with a robust variance estimator to identify the factors related to osteoporosis, adjusting for potential confounders.

Results: Overall, 2425 individuals (1166 men) aged over 60 years were included. In all, total osteoporosis was detected in 1006 (41.5%) of the participants. Using the reference value derived from Caucasian women aged 20-29 years, the age-standardized prevalence of total osteoporosis was 24.6 (95% CI: 21.9-27.3) in men, and 62.7 (95% CI: 60.0-65.4) in women. In men, osteoporosis was positively associated with age, smoking, history of fracture, and history of renal/liver diseases and negatively associated with body mass index (BMI) and diabetes. BMI, hypertriglyceridemia, and education were negatively correlated with osteoporosis in women, while years after menopause and history of fracture increased the likelihood of osteoporosis, significantly.

Conclusion: Results support the high prevalence of osteoporosis and osteopenia in the elderly population. Considering the importance of severe complications, especially fractures, comprehensive interventions should be expanded.

Citing Articles

Causal inference study of plasma proteins and blood metabolites mediating the effect of obesity-related indicators on osteoporosis.

Huang M, Xing F, Hu Y, Sun F, Zhang C, Xv Z Front Endocrinol (Lausanne). 2025; 16:1435295.

PMID: 40041284 PMC: 11876022. DOI: 10.3389/fendo.2025.1435295.


The association of dietary inflammatory index and osteosarcopenia in Iranian adults: results of iranian multicenter osteoporosis study.

Ostovar N, Fahimfar N, Ostovar A, Daneghian S J Diabetes Metab Disord. 2025; 24(1):53.

PMID: 39845907 PMC: 11748730. DOI: 10.1007/s40200-025-01558-z.


Sclerostin as a Genetic Determinant of Trabecular Bone Score in Postmenopausal Women: The Bushehr Elderly Health (BEH) Program.

Bidkhori M, Akbarzadeh M, Fahimfar N, Moroudi R, Hajivalizadeh S, Larijani B Iran J Public Health. 2024; 53(10):2371-2379.

PMID: 39544857 PMC: 11557747. DOI: 10.18502/ijph.v53i10.16724.


Dietary calcium intake among Iranian adults: Iranian Multicenter Osteoporosis Study (IMOS-2021).

Ghazbani A, Namazi N, Mansourzadeh M, Khalagi K, Ostovar N, Sanjari M PLoS One. 2024; 19(10):e0310135.

PMID: 39453896 PMC: 11508076. DOI: 10.1371/journal.pone.0310135.


The association between osteoporosis and quality of life among older adults in Southern Iran: findings from the Bushehr Elderly Health Program.

Zarinfar Y, Panahi N, Hosseinpour M, Sedokani A, Hajivalizadeh S, Nabipour I BMC Geriatr. 2024; 24(1):766.

PMID: 39289633 PMC: 11409764. DOI: 10.1186/s12877-024-05348-9.


References
1.
Leslie W, Morin S . Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Curr Opin Rheumatol. 2014; 26(4):440-6. DOI: 10.1097/BOR.0000000000000064. View

2.
Cooper C, Campion G, Melton 3rd L . Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992; 2(6):285-9. DOI: 10.1007/BF01623184. View

3.
LOVELACE R . Experimental neuropathy in rats made diabetic with alloxan. Electroencephalogr Clin Neurophysiol. 1968; 25(4):399. View

4.
Handa R, Kalla A, Maalouf G . Osteoporosis in developing countries. Best Pract Res Clin Rheumatol. 2008; 22(4):693-708. DOI: 10.1016/j.berh.2008.04.002. View

5.
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N . UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017; 12(1):43. PMC: 5397452. DOI: 10.1007/s11657-017-0324-5. View